A team led by the U.S. Department of Energy's Oak Ridge National Laboratory has unlocked the enzymatic synthesis process of rare sugars, which are useful in developing drugs with low side effects using a process more friendly to the environment.
Researchers sequence the entire genome of the Clostridium autoethanogenum bacterium, which is used to sustainably produce fuel and chemicals from a range of raw materials, including gases derived from biomass and industrial wastes.
Over the past several decades, Michael Kinch of Washington University in St. Louis says, the pharmaceutical industry has managed to dismantle itself. “It’s done a really efficient job of it,” he said. In a provocative series of articles and interviews, Kinch, the director of the Center for Research Innovation in Business at the university, has been describing the history of this dismantling and its implications for the future of medicine. The inescapable conclusion is that “The process by which drugs are discovered and developed will be fundamentally different in the future,” he says.
The liver provides critical functions, such as ridding the body of toxins. Its failure can be deadly, and there are few options for fixing it. But scientists now report in the journal ACS Applied Materials & Interfaces a way to potentially inject stem cells from tonsils, a body part we don't need, to repair damaged livers — all without surgery.
In a new study published today, Sept. 8, in the Proceedings of the National Academy of Sciences, a team of researchers from the University of Wisconsin-Madison has added a new wrinkle to the cell differentiation equation, showing that the stiffness of the surfaces on which stem cells are grown can exert a profound influence on cell fate.
A new immunotoxin works by getting shuttled into cancer cells, selectively destroying colon cancer, thanks to a quirk of biology
Researchers at Penn State have demonstrated an acoustofluidic pump powered by a piezoelectric transducer about the size of a quarter. This reliable, inexpensive, programmable pump is a crucial feature for lab-on-a-chip devices that could make the diagnosis of many global life-threatening diseases easy and affordable.
What if repairing large segments of damaged muscle tissue was as simple as mobilizing the body’s stem cells to the site of the injury? New research in mice and rats, conducted at Wake Forest Baptist Medical Center’s Institute for Regenerative Medicine, suggests that “in body” regeneration of muscle tissue might be possible by harnessing the body’s natural healing powers.
A modified version of the Clostridium novyi (C. novyi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns Hopkins Kimmel Cancer Center researchers.
As hemp makes a comeback in the U.S. after a decades-long ban on its cultivation, scientists are reporting that fibers from the plant can pack as much energy and power as graphene, long-touted as the model material for supercapacitors. They’re presenting their work, which a start-up company is working on scaling up, at the 248th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.
As the Food and Drug Administration mulls over whether to rein in the use of common antibacterial compounds that are causing growing concern among environmental health experts, scientists are reporting today that many pregnant women and their fetuses are being exposed to these substances. They will present their work at the 248th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.
Wrapping wound dressings around fingers and toes can be tricky, but for burn victims, guarding them against infection is critical. Today, scientists are reporting the development of novel, ultrathin coatings called nanosheets that can cling to the body’s most difficult-to-protect contours and keep bacteria at bay. They’re speaking about their materials, which they’ve tested on mice, at the 248th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.
UC San Francisco researchers have identified cells’ unique features within the developing human brain, using the latest technologies for analyzing gene activity in individual cells, and have demonstrated that large-scale cell surveys can be done much more efficiently and cheaply than was previously thought possible.
Scientists at the University of Kentucky, led by nano-biotechnologist Peixuan Guo, have reported the discovery of a new, third class of biomotor, unique in that it uses a "revolution without rotation" mechanism. Recently, Guo's team reported that these revolution biomotors are widespread among many bacteria and viruses.
Laboratories at The Scripps Research Institute are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus.
While developing an important cancer drug, Wistar scientists discovered that mice without the TRAP-1 protein live healthier longer lives, with fewer tumors and signs of aging.
AMP today reaffirmed its position that the vast majority of laboratory developed procedures should continue operating under the regulation of the CLIA program at the CMS and not be subject to pre-market review by the FDA, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
A team of Whitehead Institute researchers is bringing new levels of efficiency and accuracy to one of the most essential albeit tedious tasks of bench science: pipetting. Dubbed “iPipet,” the system converts an iPad or any tablet computer into a “smart bench” that guides the execution of complex pipetting protocols.
A team of scientists in Israel and Germany have created robots that are only nanometers in length, small enough to maneuver inside the human body and possibly inside human cells.
Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists will report here today. They have devised a method for targeting venom proteins specifically to malignant cells while sparing healthy ones, reduces or eliminates side effects that the toxins would otherwise cause. Their study is part of the 248th National Meeting of the American Chemical Society, the world’s largest scientific society.
The Kavli Foundation Lecture series features two prominent scientists: one in the booming area of ionic liquids, the other in medical materials. The former has made a novel compound with the potential to lower the energy it takes to capture carbon dioxide. The latter has engineered tissues and medical materials such as a stretchy glue that could transform surgery. They are presenting at the 248th National Meeting & Exposition of the American Chemical Society.
Cyborg technology is bringing us real-life electronic skin, prosthetics and ultra-flexible circuits. Now taking this human-machine concept to an unprecedented level, pioneering scientists are working on the seamless marriage between electronics and brain signaling with the potential to transform our understanding of how the brain works — and how to treat its most devastating diseases. Their presentation is taking place at the 248th National Meeting & Exposition of the American Chemical Society.
With nothing more than a smartphone and less than $10 of trinkets and hardware supplies, students at Missouri University of Science and Technology can build their own microscopes this fall as part of a biology lab.
As one of the 10 largest medical exhibitions in the U.S., the 2014 AACC Annual Meeting & Clinical Lab Expo is the place where breakthrough innovations in clinical testing and patient care are introduced to the healthcare world. This year, many of the trailblazing products displayed by the Expo’s 650 exhibitors will include the latest diagnostic technology in the field of mobile health.
Robotic conference offers instruction to assist trained surgeons expand their minimally invasive surgical techniques.
The groundbreaking scientific studies featured at the 2014 AACC Annual Meeting & Clinical Lab Expo will include research on a blood test for Alzheimer’s that uses biochip technology, a new test to diagnose colon cancer early, a more accurate method for determining multiple myeloma prognosis, a less stressful test for sleep apnea, and the development of a bank of biospecimens from pregnant women that could prove crucial for women’s health research.
Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. One pioneering approach uses nanoparticles to jumpstart the body’s ability to fight tumors
COLA, the largest private accreditor of medical laboratories serving more than 8,000 across the U.S., successfully concluded its 2014 Leadership Summit in April. More than 30 thought leaders in health care, including physicians, regulators, public health experts, medical laboratory scientists, manufacturers, nurse practitioners and more gathered in San Francisco to discuss the future of laboratory medicine in the context of the Affordable Care Act (ACA). The group explored the implications of the dynamics of ACA and changing payment policies on quality and learning in laboratory medicine.
The nation’s healthcare system -- and with it, the laboratory community – is undergoing a period of tremendous change as The Affordable Care Act begins implementation and new healthcare delivery models such as The Patient-Centered Medical Home (PCMH) and Accountable Care Organizations (ACOs) proliferate. With more than 70 percent of medical decisions based on lab data, laboratories are emerging as vital partners of these new healthcare teams. Labs are uniquely qualified to use the patient data they capture to provide feedback to allied health professionals that can increase efficiency and contain health-care costs while improving patient care.
COLA Inc., based in Columbia, MD, an independent, nonprofit laboratory CLIA-accreditation organization, accrediting more than 7,000 clinical diagnostic labs on July, 2013, launched a new education subsidiary, COLA Resources Inc. (CRI®), whose mission is to “Provide educational & consultative services aimed at improving laboratory medicine and patient care.”
Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearance to market its Vitamin D assay for Clinical Chemistry Analyzers. In line with the rapid increasing clinical demands for testing of this important biomarker, Diazyme’s new Vitamin D assay, utilizing its femtoquantTM technology (a sensitive homogenous enzyme-immunoassay platform), provides the first fully automated Vitamin D test for use on general clinical chemistry analyzers. Diazyme’s Vitamin D assay measures total 25-hydroxy Vitamin D (sum of 25-(OH)D3 + 25-(OH)D2 ) levels.
Applied and effortless simplicity of Burkert products have always been something to rely on – now we have added pure flexibility to the list of standards you can expect. The unique Pneumatic Dosing unit from Burkert – ultra precision and repeatability of fluid dosing come together with a flexible, customizable design giving you precisely the results that matter to you. Whether your world is dosing pharma media or syrup, vaccines or coffee flavors, wide ranging performance just met your changing needs.
As a leading educator in laboratory medicine, COLA Resources Inc.’s (CRI®) goal is to continually update our education platform to reflect and support education regarding changes in regulatory requirements. The most recent regulatory changes impacting the clinical laboratory is the Centers for Medicare and Medicaid Services (CMS) new Individualized Quality Control Plan (IQCP) quality control interpretive guidelines. CRI®’s IQCP program is designed to assist clinical laboratories develop and implement their own individualized quality control. The program contains an innovative and intuitive software program IQCP E-Optimizer™ and an IQCP Implementation Guide.
Attending the CRI® Symposium for Clinical Laboratories, affords participants the opportunity to participate in discussions centered on EDUCATION FOR LABORATORY EXCELLENCE – making a positive impact for quality patient care. This year’s symposium will be held October 15-18, 2014 at the Buena Vista Palace Hotel & Spa Lake Buena Vista (Orlando), FL. Participants can attend a wide selection of educational sessions, earn up to 20 CME or P.A.C.E® credits, network with other healthcare professionals and visit the exhibit hall featuring the latest laboratory technology, equipment and supplies.
A partnership born out of the URI Institute for Immunology and Informatics has resulted in a new web-based tool designed to help manufacturers of protein-based therapeutics improve the safety of their manufacturing processes, avoiding problems that caused the U.S. Food and Drug Administration to suspend a clinical trial in 2012.
Whitehead Institute scientists have genetically and enzymatically modified red blood cells to carry a range of valuable payloads—from drugs, to vaccines, to imaging agents—for delivery to specific sites throughout the body.
Using a type of human stem cell, Johns Hopkins researchers say they have created a three-dimensional complement of human retinal tissue in the laboratory, which notably includes functioning photoreceptor cells capable of responding to light, the first step in the process of converting it into visual images.
When stem cells are used to regenerate bone tissue, many wind up migrating away from the repair site, which disrupts the healing process. But a University of Rochester research team makes use of a technique that keeps the stem cells in place, resulting in faster and better tissue regeneration.
A team led by researchers at The Scripps Research Institute has used advanced electron microscopy techniques to determine the first accurate structural map of Mediator, one of the largest and most complex “molecular machines” in cells.
A clearer understanding of how mussels stick to surfaces could lead to new classes of adhesives that will work underwater and even inside the body.
UNC School of Medicine researchers have provided the first quantitative evidence that mucins – the protein framework of mucus – are significantly increased in cystic fibrosis patients and play a major role in failing lung function.
Collaboration Combined with Revolutionary Technology opens new potential to identify new biomarkers and therapeutic points of intervention for use in the development of new Alzheimer’s treatments
Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool to identify genetic mutations that contribute to a person’s increased risk for developing common, complex diseases, such as cancer.
Scientists have developed a powerful tool called pVAAST that combines linkage analysis with case control association to identify disease-causing mutations in families faster and more precisely than ever before.
A new technology under development at the Georgia Institute of Technology could one day provide more efficient delivery of the bone regenerating growth factors with greater accuracy and at a lower cost.
Protea Biosciences Group, Inc. (OTCQB:PRGB) announced it has entered into a research collaboration with the University of Southampton, a leading biomedical and clinical research institution located in the United Kingdom. The collaboration will partner Protea’s proprietary direct molecular imaging technology and capabilities with a team of Alzheimer’s researchers at the University of Southampton, to study the molecular mechanisms of the aged brain, in order to identify markers that may indicate risk of developing Alzheimer’s disease.
A paper from University of Alabama at Birmingham researchers in the journal Science about the fertility of roundworms may have implications for everything from captive pandas to infertile couples struggling to conceive.
Mice severely disabled by a condition similar to multiple sclerosis (MS) were able to walk less than two weeks following treatment with human neural stem cells. The finding, which uncovers potential new avenues for treating MS, will be published online on May 15, 2014, in the journal Stem Cell Reports.
Feeling sluggish? Gaining weight? What you need is a shot in the arm, claim advertisers for trendy vitamin B12 injections.Don’t let marketers needle you.“If medical testing confirms that an individual has a vitamin B12 deficiency, a vitamin B12 supplement will help. But if a B12 deficiency has not been identified by a physician or primary care doctor, there is no need to waste energy and money on B12 shots,” says Ashley Barrient, clinical dietitian, Loyola Center for Metabolic Surgery & Bariatric Care.
Ram Sasisekharan’s startups provide novel methods to fight disease and make better drugs.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right